Create Free Account

By creating account you will get access to hot stocks & personalised emails

Atomo Diagnostics Ltd

Healthcare AU AT1

0.019AUD
-0.001(5.00%)

Last update at 2024-12-19T04:59:00Z

Day Range

0.020.02
LowHigh

52 Week Range

0.020.04
LowHigh

Fundamentals

  • Previous Close 0.02
  • Market Cap12.14M
  • Volume1244438
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-5.42349M
  • Revenue TTM4.09M
  • Revenue Per Share TTM0.006
  • Gross Profit TTM -0.50136M
  • Diluted EPS TTM-0.01

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -9.95763M -5.70685M -6.02121M -9.21810M -5.05511M
Minority interest - - - - -
Net income -9.95763M -5.72232M -6.43454M -14.79155M -5.05511M
Selling general administrative 4.86M 4.15M 3.82M 3.01M 3.26M
Selling and marketing expenses - - - - -
Gross profit 0.67M 4.25M 3.42M 3.19M 0.10M
Reconciled depreciation 1.89M 2.00M 1.32M 0.70M -
Ebit -11.20790M -5.69138M -6.01343M -3.93293M -4.22355M
Ebitda -9.31611M -3.69398M -4.69510M -3.22981M -
Depreciation and amortization 1.89M 2.00M 1.32M 0.70M -
Non operating income net other - - - - -
Operating income -11.20790M -5.69138M -6.01343M -3.93293M -4.64050M
Other operating expenses 13.75M 20.81M 13.23M 9.61M 0.88M
Interest expense 0.11M 0.02M 0.00779M 5.29M 0.38M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.01M 0.00546M 0.08M 0.02M 1.02M
Net interest income 0.06M -0.01001M 0.08M -5.26332M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.05912M 0.02M 0.41M 5.57M -0.80554M
Total revenue 2.54M 12.34M 6.72M 5.37M 0.54M
Total operating expenses 11.88M 12.72M 9.93M 7.44M -
Cost of revenue 1.88M 8.09M 3.30M 2.17M 0.44M
Total other income expense net 1.19M -0.01547M -0.00779M -5.28518M -
Discontinued operations - - - - -
Net income from continuing ops -9.95763M -5.70685M -6.02121M -9.21810M -
Net income applicable to common shares -9.95763M -5.70685M -6.02121M -9.21810M -5.05511M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 11.38M 16.47M 26.62M 32.24M 36.10M
Intangible assets - 3.30M 3.57M 3.00M 1.52M
Earning assets - - - - -
Other current assets - - - - 1.27M
Total liab 1.29M 1.68M 1.81M 2.15M 1.62M
Total stockholder equity 10.08M 14.79M 24.81M 30.09M 34.48M
Deferred long term liab - 1.94M 2.20M 2.03M -
Other current liab 0.57M 0.96M 1.00M 1.41M 0.53M
Common stock 70.09M 68.04M 68.04M 67.92M 66.51M
Capital stock - 68.04M 68.04M 67.92M 67.49M
Retained earnings -60.09034M -53.54975M -44.02647M -38.31962M -32.32936M
Other liab - 0.10M 0.09M 0.02M 0.11M
Good will - - - - -
Other assets 0.00000M 1.94M 2.20M 2.03M -
Cash 3.69M 6.47M 12.97M 17.95M 27.10M
Cash and equivalents - - - - -
Total current liabilities 1.19M 1.49M 1.53M 2.13M 1.51M
Current deferred revenue 0.05M 0.19M - - -
Net debt -3.60332M -6.21544M -12.62560M -17.87893M -27.04830M
Short term debt 0.08M 0.17M 0.16M 0.07M 0.05M
Short long term debt - - - - -
Short long term debt total 0.08M 0.25M 0.34M 0.07M 0.06M
Other stockholder equity - 0.30M 0.80M 0.49M 0.30M
Property plant equipment - 2.74M 3.98M 3.75M 1.51M
Total current assets 7.59M 10.43M 19.07M 25.48M 33.07M
Long term investments - - - - -
Net tangible assets - 13.43M 23.44M 27.09M 32.96M
Short term investments - - - - -
Net receivables 2.06M 1.82M 2.68M 4.49M 3.49M
Long term debt - - - - 0.00000M
Inventory 1.84M 2.14M 3.42M 3.04M 1.21M
Accounts payable 0.48M 0.18M 0.38M 0.65M 0.93M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.09M 0.30M 0.80M 0.49M 0.30M
Additional paid in capital - - - - -
Common stock total equity - - - - 67.49M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2.07M - - - -
Deferred long term asset charges - - - - -
Non current assets total 3.79M 6.04M 7.56M 6.76M 3.03M
Capital lease obligations - 0.25M 0.34M 0.07M 0.11M
Long term debt total - 0.08M 0.18M 0.00000M 0.00768M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.40128M -2.30550M -5.89757M -1.99314M -
Change to liabilities 0.06M -0.73185M 0.36M 0.25M 0.00744M
Total cashflows from investing activities -0.40128M -2.30550M -5.89757M -1.99314M -0.81336M
Net borrowings -0.17075M -0.04994M -0.11335M 5.80M 5.80M
Total cash from financing activities -0.17075M 0.02M 1.00M 33.61M 2.43M
Change to operating activities -0.00236M 0.03M 0.03M 0.13M 0.02M
Net income -9.95763M -5.72232M -6.02121M -9.21810M -5.05511M
Change in cash -6.49608M -4.98012M -9.15732M 25.25M -0.13789M
Begin period cash flow 12.97M 17.95M 27.10M 1.86M -
End period cash flow 6.47M 12.97M 17.95M 27.10M 1.86M
Total cash from operating activities -5.84767M -3.72492M -4.22525M -6.26193M -1.83849M
Issuance of capital stock - 0.07M 1.11M 27.81M -
Depreciation 1.44M 2.00M 1.32M 0.70M 0.56M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory 1.28M -0.37715M -1.83257M -0.42196M -0.52922M
Change to account receivables 0.82M 1.71M 1.37M -2.94112M 2.35M
Sale purchase of stock 0.00000M 0.07M 1.11M 27.81M 2.44M
Other cashflows from financing activities -0.17075M -0.04994M -0.11335M 15.14M -0.01239M
Change to netincome 0.06M 0.27M 0.55M 5.25M 0.81M
Capital expenditures 0.40M 2.31M 5.90M 1.99M 0.74M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.07M 0.00546M 0.09M -0.86201M 0.02M
Stock based compensation - - - - -
Other non cash items - 3.72M 4.70M 8.51M -
Free cash flow -6.24895M -6.03042M -10.12282M -8.25507M -

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AT1
Atomo Diagnostics Ltd		 -0.001 5.00% 0.02 - 54.95 2.97 1.27 2.25 -1.932
COH
Cochlear Ltd		 -3.32 1.13% 291.11 53.50 45.87 8.50 10.43 8.47 32.70
PNV
Polynovo Ltd		 -0.11 5.19% 2.01 206.00 138.89 13.79 20.21 13.83 352.63
AVH
Avita Therapeutics Inc		 -0.2 5.13% 3.70 - - 9.07 28.09 5.79 -10.0538
EBR
Ebr Systems Inc CDR		 0.12 14.53% 0.98 - - - 6.51 - -3.6785

Reports Covered

Stock Research & News

View All

Profile

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers rapid diagnostic test devices for HIV screening, pregnancy test, and respiratory test. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

Atomo Diagnostics Ltd

3-5 George Street, Leichhardt, NSW, Australia, 2040

Key Executives

Name Title Year Born
Mr. John Michael Kelly Founder, CEO, MD & Director NA
Mr. William Edward Souter BCom, LLB (Adel), IPAA Chief Financial Officer NA
Ms. Chandra Sukumar Chief Operating Officer NA
Mr. Jim P. McMenamy Head of Bus. Devel. & Partnerships of the Americas NA
Ms. Anna Tucker Head of Bus. Devel. & Partnerships of Europe, Middle East and Africa NA
Mr. Tharun Kuppanda Company Sec. NA
Mr. Jim P. McMenamy Head of Business Development & Partnerships of the Americas NA
Ms. Anna Tucker Head of Business Development & Partnerships of Europe, Middle East and Africa NA
Ms. Maria Clemente Company Secretary NA
Mr. Jim P. McMenamy Head of Business Development & Partnerships of the Americas NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.